FDA Greenlights First Once-Weekly Basal Insulin: A New Era for Type 2 Diabetes Care 2 min read Pharma News FDA Greenlights First Once-Weekly Basal Insulin: A New Era for Type 2 Diabetes Care Pharm'Up The landscape of diabetes management has shifted. On March 27, 2026, the FDA officially approved Awiqli® (insulin... Read More Read more about FDA Greenlights First Once-Weekly Basal Insulin: A New Era for Type 2 Diabetes Care
Pharm'Up 
Pharm'Up 
